Comments
Commented by Fabian Lorenz on November 7th, 2024 | 07:15 CET
TUI, Evotec, BioNxt Solutions: Short squeeze potential, Price drops, and Momentum
BioNxt Solutions' stock has gained 50% since the end of August. The chances are good that the momentum will continue for the biotech company. The stock would need to more than double to reach its January level. The industry environment is favorable, the news flow is positive, and takeover speculation exists. Takeover speculation is perhaps the only positive factor for Evotec's share at the moment. The operational development is certainly not. Yesterday, the Company reported a significant drop in earnings. Is there any improvement in sight? Operationally, TUI has been doing well for quite some time. With a jump in the share price, the stock is now setting its sights on the resistance at EUR 8. Could there even be a short squeeze? Analysts may also shift to the bull camp.
Read
Commented by Juliane Zielonka on November 7th, 2024 | 07:00 CET
Vidac Pharma, BioNTech, Bayer - Billion-Dollar Gene Therapy Market Attracts Investors
Two trends are emerging in the pharmaceutical industry: personalized medicine, which tailors therapies to the genetic profile of individual patients, and the development of highly specific active ingredients that target biological mechanisms. Vidac Pharma is one of the companies focusing on these targeted therapies and recently received a groundbreaking US patent for its innovative approach to normalizing cancer cell metabolism - a concept known as the "Warburg effect reversal." BioNTech is driving its transformation from COVID-19 vaccine producer to cancer specialist, with promising Phase II trials underway for treatments targeting lung and breast cancers. Bayer, meanwhile, is under pressure due to disappointing sales of its partner Regeneron's eye drug Eylea® – the second most important product in the portfolio, which has to hold its own against growing competition. Where is an investment worthwhile?
Read
Commented by André Will-Laudien on November 6th, 2024 | 08:00 CET
US election and the biotech sector – A hot November is on the cards! BioNTech, Pfizer, Nyxoah, Bayer or Evotec?
With anticipation building for both the Q3 earnings season and the US election results, the markets are in a wait-and-see mode. Democrat frontrunner Kamala Harris is said to be committed to continuing the successful policies of her predecessor Joe Biden. Of course, science, research and climate protection are in the spotlight. Her rival, Donald Trump, is said to be more concerned with strengthening the traditional economy, where automotive engineering, the defense industry and security companies come to the fore. Additionally, markets are looking to central banks for cues, as lower interest rates would be a boon for the biotech sector. Here are some investment ideas for dynamic investors in this promising climate.
Read
Commented by Fabian Lorenz on November 6th, 2024 | 07:35 CET
Soaring share prices, battery revolution, sales record! BYD, Plug Power and Altech Advanced Materials shares!
Altech Advanced Materials is getting ever closer to the battery revolution. And it is all happening in Germany! The prototype of their revolutionary solid-state battery is operational, and there is an initial declaration of intent in the three-digit million-euro range. The Company is valued at around EUR 25 million, providing solid reasons for a potential rapid 50% price increase. Meanwhile, Plug Power's stock has shot up a good 20% since Friday. Is this just a blip, or is there more to it for the former hydrogen high-flyer? In any case, Plug shareholders should be cautious next week. There is also a lot to be said for rising prices at BYD. The Chinese electric carmaker is in a thrilling race with Tesla for industry leadership, and analysts are forecasting over a 20% upside potential.
Read
Commented by Armin Schulz on November 6th, 2024 | 07:25 CET
K+S, Almonty Industries, Barrick Gold – Commodities: The secret ingredient for your investment success
In times of economic uncertainty, investing in commodities is becoming increasingly attractive for investors. Not only do commodities offer protection against inflation, but they are also essential building blocks for technological innovation and industrial growth. This market offers natural diversification for any portfolio, from precious metals to energy sources and agricultural products. Historically, commodities have shown that they provide stable returns and long-term value appreciation potential, especially in times of crisis. For investors with foresight, the commodities sector could be a worthwhile addition to their investment strategies.
Read
Commented by Juliane Zielonka on November 6th, 2024 | 07:10 CET
123fahrschule, Intel, Mercedes-Benz - Between disruption and evolution: New business models in focus
Companies in Germany and the US are undergoing a profound transformation: Traditional business models are being digitally transformed, and established market leaders must defend their positions. As Germany's largest driving school chain, 123fahrschule SE is revolutionizing a EUR 2.75 billion market through digitalization and driving simulator technology. From 2025, 50% of theory lessons can be done online - a turning point for the industry. Despite a solid financial position, Mercedes-Benz is struggling with a profit decline in the third quarter of 2024 from EUR 3.4 billion to EUR 1.2 billion. The premium manufacturer is investing heavily in e-mobility, while around 140,000 jobs in the German automotive industry will be lost by 2035. Intel, which has left the Dow Jones after 25 years, is transforming from a pure processor manufacturer to a contract manufacturer. With the new Intel 18A technology and planned cost savings of USD 10 billion by 2025, the chip giant is showing the first signs of success in its transformation.
Read
Commented by André Will-Laudien on November 5th, 2024 | 07:30 CET
The tension is rising! Quarterly figures from BioNTech and Evotec – Doubling potential for BioNxt, Grenke and SMCI
The reporting season has just started, and the first profit warnings are already here. Grenke warns of increasing provisions, Super Micro Computer is keen to submit figures, but the auditor has resigned. There is good news, however, from Evotec, BioNTech, and BioNxt, with their bottoming phases seemingly behind them. In an environment of falling interest rates, biotech stocks could now appear in a new light. Currently, everyone is looking west because the world's largest economic power is electing a new president. Once the uncertainty clears, markets may continue their positive trend. We have some interesting investment ideas in store.
Read
Commented by Armin Schulz on November 4th, 2024 | 13:45 CET
Desert Gold Ventures Special: A Jewel for the Well-Informed Investor?
With geopolitical tensions, a potential gold-backed BRICS currency, and declining interest rates, gold is experiencing a true renaissance – and the recent rally, which pushed the price towards USD 2,800 per ounce, has sparked investor interest like never before. As the gold market gains momentum, many investors are focusing on companies that could benefit from this favorable market environment. One of the most exciting players in this space is Desert Gold Ventures (TSXV: DAU), a rising star in the West African mining landscape. What makes Desert Gold a potential gold mine for investors? A well-informed investor should know these key factors! Read on to learn more.
Read
Commented by Armin Schulz on November 4th, 2024 | 07:15 CET
Commerzbank, Desert Gold, Covestro – Potential check for takeover candidates
In a dynamic economy where opportunities and risks are closely intertwined, stocks affected by takeover offers or corresponding rumors offer a unique potential for investors. These situations not only present the chance for sharp price increases but also provide fascinating insights into the strategic considerations of companies and markets. When major players seek to gain new perspectives or create synergies, investors have ample opportunities to benefit from a potential uptrend. In this article, we highlight three companies that are either on the verge of an offer, have the potential to be a takeover target, or are already the subject of a takeover bid.
Read
Commented by Stefan Feulner on November 4th, 2024 | 07:00 CET
Exxon, F3 Uranium and JinkoSolar with tailwinds
The past trading week was marked by high volatility as the tech giants released their third-quarter results. Given the still unresolved election in the United States, it is unlikely that the volatility will subside soon. Investors should, therefore, prepare themselves for another rollercoaster ride on the markets until a final election result is confirmed.
Read